Back to Search
Start Over
Urine Tenofovir Levels Measured by a Novel Immunoassay Predict HIV Protection
- Source :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 72, iss 3
- Publication Year :
- 2020
- Publisher :
- eScholarship, University of California, 2020.
-
Abstract
- New tools are needed to support PrEP adherence for individuals at risk for HIV, including those that enable provision of real-time feedback. In a large, completed PrEP trial, adequate urine tenofovir levels measured by a novel immunoassay predicted HIV protection and showed good sensitivity and specificity for detectable plasma tenofovir.
- Subjects :
- Partners PrEP Study Team
Immunoassay
Anti-HIV Agents
Prevention
HIV prevention
Clinical Trials and Supportive Activities
HIV
HIV Infections
Biological Sciences
Medical and Health Sciences
Microbiology
PrEP
urine
Medication Adherence
Infectious Diseases
Good Health and Well Being
Clinical Research
HIV/AIDS
Emtricitabine
Humans
ELISA
Pre-Exposure Prophylaxis
Infection
Tenofovir
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 72, iss 3
- Accession number :
- edsair.od.......325..50d25b6cca5e2ca51c8eaff783333827